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Abstract: Background. Craniofacial anomalies and minor neurological dysfunction (MNDs) have
been identified, in literature, as risk factors for neurodevelopmental disorders. They represent physical
indicators of embryonic development suggesting a possible contributory role of complications during
early, even pre-conceptional, phases of ontogeny in autism spectrum disorders (ASD). Limited
research has been conducted about the co-occurrence of the two biomarkers in children with ASD.
This study investigates the associative patterns of cranio-facial anomalies and MNDs in ASD children,
and whether these neurodevelopmental markers correlate with intensity of ASD symptoms and
overall functioning. Methods. Caucasian children with ASD (n = 33) were examined. Measures were
based on five anthropometric cranio-facial indexes and a standardized and detailed neurological
examination according to Touwen. Relationships between anthropometric z-scores, MNDs and
participant characteristics (i.e., age, cognitive abilities, severity of autistic symptoms measured using
the Childhood Autism Rating Scale (CARS) checklist) were assessed. Results. With respect to specific
MNDs, significant positive correlations were found between Cephalic Index and Sensory deficits
(p-value < 0.001), which did not correlate with CARS score. Importantly, CARS score was positively
linked with Intercanthal Index (p-value < 0.001), and negatively associated with posture and muscle
tone (p-value = 0.027) and Facial Index (p-value = 0.004). Conclusion. Our data show a link between
a specific facial phenotype and anomalies in motor responses, suggesting early brain dysmaturation
involving subcortical structures in cerebro-craniofacial development of autistic children. This research
supports the concept of a “social brain functional morphology” in autism spectrum disorders.
Keywords: autism spectrum disorders; morphology; minor neurological dysfunctions; neurodevelopment
1. Introduction
Over the past few years, there has been mounting evidence to support the neurodevelopmental
model of autism spectrum disorders (ASD), which postulates that the etiological origins of the disease
can be traced to events in the prenatal period [1].
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Several studies have investigated brain structure and brain function in subjects with
neurodevelopmental impairments including; autism spectrum disorders (ASD), ADHD and
schizophrenia. These studies identified abnormal brain structure and a higher incidence
of developmental brain anomalies, resulting in clinical, cognitive, electrophysiological and
neuroanatomical markers. [2,3]. Among these so-called “neurodevelopmental” markers, minor physical
abnormalities (MPAs) and minor neurological dysfunction (MNDs) have been suggested as risk factors
for ASD and, correspondingly, as sensitive physical indicators of embryonic development [4–6].
MPAs are neurodevelopmental markers which manifest as unusual morphological features of
the face or physique. MPAs can manifest as early as the first or early second trimester, and have
consistently been linked to a biological vulnerability, which continues into adolescence and young
adulthood [5–7].
MPAs associated with ASD, have been observed across multiple areas of the body. In particular,
re-occurrence of anomalies in the craniofacial region, suggests specific facial characteristics related
to subpopulations of ASD. There has been consistent evidence that the development of the face is
intimately entwined with development of the brain; their tissues share common origins, and develop
in close coordination, as a result of physical adjacency and reciprocal molecular signaling [8].
Previous studies [9–11] have shown that facial morphology differed significantly in individuals
with ASD diagnoses; identifying subsets of ASD boys, with distinctive craniofacial morphology,
associated with greater severity of ASD symptoms. This could suggest an “ASD facial phenotype”,
representing a new physical biomarker which could be used to improve ASD diagnosis.
The concept of minor neurological dysfunction (MND) can be useful when describing
neurodevelopmental impairments in ASD children. In recent years, attention has focused upon
sensory-motor abnormalities observed in subjects with ASD, categorizing these as “associated
symptoms”. Infants and children with ASD have been found to display altered motor development,
clumsiness, retention of primitive reflexes, deficits in gross and fine motor movement, impaired
postural control and abnormal gait sequencing [12–14].
These dysfunctions have neurodevelopmental relevance, indicating specific alterations
in the connecting fiber systems of the central nervous system, which result in impaired sensory-motor
performance. An adverse event at any stage of neurological development may result in various
clinical manifestations of MNDs, at different life stages [14]. Two etiologically and clinically different
forms of MNDs can be distinguished: simple and complex MNDs. Simple MND may be regarded
as an expression of typical, but non-optimal brain wiring. In contrast, complex MND denotes
clinically relevant brain dysfunction and is considered to be a borderline form of cerebral palsy [14].
In the literature, children with MNDs show higher rates of MPAs than children without MND,
suggesting a possible contributory role of complications during early, even pre-conceptional, phases of
ontogeny [14–17].
Despite evidence to suggest a link between minor neurological dysfunctions and minor anomalies
of the face and limbs, in neurodevelopmental conditions such as schizophrenia [18] or developmental
coordination disorders [14], comparatively little is known about the co-occurrence of the two biomarkers
in children with ASD.
The aim of the present study was to investigate the associative patterns of cranio-facial anomalies
and MNDs in ASD children, and to determine whether these neurodevelopmental markers correlate
with intensity of ASD symptoms and overall functioning. More generally, assessment of MPAs and
MNDs may assist in the diagnostic protocol for neurodevelopmental disorders.
2. Methods
2.1. Participants
A total sample of 33 children over a total population of 65 individuals with ASD diagnosis
attending at Tours University Hospital Center (Tours, France) was selected. The subjects’ selection is
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showed in Figure 1. The sample consisted of Caucasian children of European origin, as normative
physical data have been well-defined in the Caucasian population [9,10]. The exclusion criteria regard
non-Caucasian ASD children, ASD children with clinical diagnosis of a co-morbid psychiatric or
medical condition such as epileptic seizures or frank neurological pathology (e.g., cerebral-palsy,
muscular dystrophy or evidence of other) and ASD children in pubertal age. The latter was an exclusion
criterion since puberty is associated with a substantial decline in the number of dysfunctional clusters
of MND. All subjects met the current ICD-10 criteria for clinical diagnosis of “pervasive developmental
disorders (PDD)” according to the World Health Organization’s (WHO) International Classification of
Diseases, 10th edition (ICD-10). ASD was diagnosed using standardized diagnostic tools (mean age at
assessment: 7.6 years; standard deviation SD: 2.2). The sample of ASD children included those who
met diagnostic criteria for; childhood autism (F84.0, n = 21), atypical autism; (F84.1, n = 9), Asperger’s
syndrome (F84.5, n = 2) and other PDD (F84.9, n = 1). ADI-R [19] complemented the clinical diagnosis
of ASD children. One child classified as having PDD not otherwise specified on the ADI-R (below
threshold on 1 domain by 1 point) was also included.
Figure 1. Flow-chart diagram of subjects’ selection.
The study was conducted in accordance with the basic principles of the Declaration of Helsinki.
Clinical data, including behavioral and cognitive evaluation, were collected from medical records,
stored in a bio-clinical database. This was approved by CNIL, the French data protection authority.
An extensive, multidisciplinary child neuro-psychiatric assessment was carried out for each
subject. Assessment consisted of a preliminary developmental history, medical examination and
neuropsychological assessment.
Behavioral assessment was carried out using the Childhood Autism Rating Scale (CARS) [20].
The CARS evaluates the severity of autistic behaviors in 14 functional areas by assigning a score
from 1 to 4. An overall score is calculated by adding scores from all functional areas. It enables
the assessment of severity of autistic symptoms, and the stratification of patients into three levels:
“severely autistic” (score between 37 and 60), “mildly to moderately autistic” (score between 30 and
36.5), and “absence of ASD” (score less than 30). The questionnaire can be carried out in around
20–30 min. Clinical psychologists were trained on these scales and were experienced with children
with ASD. Intellectual functioning was evaluated using the Weschler Abbreviated Intelligence Scale-III,
(WAIS III) [21], allowing a global Intellectual Quotient (IQ), a non-Verbal Quotient (nVQ) and a Verbal
Quotient (VQ) to be obtained for all ASD children.
All ASD children received a comprehensive physical examination, to exclude the presence of
a clinically detectible genetic syndrome associated with gross dysmorphic features and autistic-like
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symptoms. The examination was conducted by a pediatric team, in the same hospital site, examiners
were blind to group status. Written informed consent was obtained from the parents or guardians of
each participant.
2.2. Morphological Assessment
For a detailed description of the morphological assessment protocol see Tripi et al. [11] Cranio-facial
examination of the ASD group employed a mixed approach of computerized photogrammetry and
classic anthroposcopy. The examination was conducted by the same author (GT) in the same
testing rooms. Photographs were obtained using a high-resolution digital camera. The Euclidean
measurements, based on anthropometric landmarks and 2D photogrammetric examinations, were
obtained using image analysis software (FlashCAD®, Digitarch srl, Rome, Italy) [6]. Standardized
cranio-facial photographs were taken with the camera lens aligned with the subject’s Frankfort
horizontal plane [22]. An internal measure of scale (adhesive paper sticker) was placed on the glabella
landmark for the frontal view, and on the condylion of the mandible for the profile view.
Anthropometric linear measurements and landmarks on the soft tissue of the face and head, were
based on five cranio-facial indexes, borrowed from the works of Farkas et al. [23]. Each skull-facial
index was compared with the tables of anthropometric norms for Caucasian subjects.
2.3. Neurological Assessment
All ASD children underwent a standardized and detailed neurological examination according
to Touwen [13]. This is a standardized and age-specific examination, which focuses on minor
neurological dysfunctions. The following clusters were evaluated: posture and muscle tonus; reflexes;
involuntary movements; coordination and balance; fine motor movements; associated movements;
sensory functions and cranial nerve function. The assessment was conducted by the same author
(GT), in the same testing rooms, over a duration of one hour. The assessment criteria used to identify
MNDs was age specific; as developmental changes in the nervous system are known to induce changes
in the expression and prevalence of MNDs. Literature data [14] indicate that the rate of MNDs at
preschool age in the general population is relatively low, reaching its peak before the emergence of
puberty. Signs of dysfunction are taken into account only if they occur in cluster. The presence of a single
sign of dysfunction, such as isolated positive Babinski signs, does not lead to a diagnosis of MND.
Clusters, as defined in clinical practice, are organized according to the functional neuro-behavioral
subsystems of the nervous system [24].
The original protocol suggested by Touwen [13] was adapted slightly. Adaptation consisted of
removal of: following an object with rotation of the trunk whilst sitting, palmo-mental reflex, Mayer
and Leri reflexes, cremasteric reflex, Galant response, examination of the spine whilst the child is lying
down, examination of the hip joints, sitting up without the help of hands, fundoscopy and localization
of sound. These items were omitted as some authors [25] suggest they have little value in terms of
determining the presence or absence of clusters of MNDs in the general population.
According to the classification of Hadders-Algra [14,16,17], ASD children were classified as
neurologically normal if having no abnormal domains. If one or two abnormal domains were classified
as s-MND and three or more abnormal domains as c-MND.
2.4. Statistical Methods
Statistical analyses were carried out using R software (version 3.6.3) available at https://cran.
r-project.org/. Categorical variables were summarized as counts and percentages, discrete and
continuous variables as mean, standard deviation (SD) and range. Z-scores of Cranio-facial Indexes
were calculated using tables of anthropometric norms for Caucasian subjects, developed by Farkas
et al. [23]. Relationships between anthropometric index (cephalic, facial, intercanthal, nasal and
mouth-face) z-scores and participant characteristics (age, sex, global QI, VQ-nVQ, severity of autistic
symptoms measured using the CARS score) and MNDs (posture and muscle tone, reflex abnormalities,
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involuntary movements, coordination and balance, fine motor dysfunction, associated movements,
sensory deficits, cranial nerve dysfunction) were assessed using Pearson’s correlations. A standard
multiple regression model was applied to assess craniofacial Index z-scores (as response variables)
in relation to participant characteristics and MNDs (as independent variables), adjusted for participant
characteristics. A linear regression was applied to explain CARS score in relation to demographic
variables, craniofacial Indexes, MNDs, net of global QI. Results reporting p-value < 5% were considered
statistically significant.
3. Results
The study sample included 33 children, (28 of them are males), aged 91.5 (26.7) months with
a range of 4 and 12 years of age. Demographic, clinical and anthropometric characteristics of the sample
are shown in Table 1. The prevalence of MNDs in our sample was 91%, of which 17 children (57%)
were affected by simple MND and 13 children (43%) had complex MNDs. The most frequent minor
neurological dysfunction was associated movements (58%), and more than half of the sample suffered
from sensory deficits (52%). Fine-motor dysfunction was present in 33% of the sample whilst posture
and muscle tone and coordination and balance were affected in 30% of children (Table 2).
Table 1. Demographic, clinical and anthropometric characteristics of the 33 children with ASD.
Demographic and Clinical Variables Anthropometric Variables
Mean (SD) Mean (SD) Z-Score
Age in months 91.5 (26.7) Cephalic Index 74.2 (5.1) −0.51 (1.2)
CARS 30.4 (5.3) Facial Index 83.9 (6.6) −0.17 (1.3)
Global QI 59.9 (24.2) Intercanthal Index 38.7 (2.2) 0.20 (1.0)
VQ 50 (24.4) Nasal Index 72.5 (5.9) 0.27 (0.9)
nVQ 70 (26.8) Mouth-Face Index 36.7 (2.1) −0.09 (0.9)
MND Total 2.2 (1.5)
Table 2. Prevalence of the specific types of MND in ASD children.
Type of Mild Neurological Dysfunction
n (%)
Posture and muscle tone 10 (30%)
Reflex abnormalities 1 (3%)
Involuntary movements 3 (9%)
Coordination and balance 10 (30%)
Fine motor dysfunction 11 (33%)
Associated Movements 19 (58%)
Sensory deficits 17 (52%)
Cranial nerve dysfunction 3 (9%)
s-MND 15 (45%)
c-MND 14 (42%)
The correlations between anthropometric z-scores, demographic characteristics, global QI, CARS
and MND are shown in Table 3. Most of these correlations were previously described in our study [11].
Moreover, significant, large positive correlations were found between cephalic index and sensory
deficits (r = 0.547, p-value < 0.001) and between cephalic index and c-MND (r = 0.469, p-value = 0.005).
Conversely, a negative correlation was discovered between Cephalic Index and s-MND (r = −0.448,
p-value = 0.008). Facial index is significantly, negatively correlated with CARS score (r = −0.505,
p-value = 0.002) and Sensory deficits (r = −0.532, p-value = 0.001), and positively correlated with
complex MND (r = 0.468, p-value = 0.005). While a moderate correlation was observed between facial
index and global QI (r = 0.348, p-value = 0.046). Furthermore, moderate correlations were discovered
between intercanthal index and CARS score (r = 0.384, p-value = 0.027) and reflex abnormalities (r =
0.381, p-value = 0.028) (Table 3).
Brain Sci. 2020, 10, 566 6 of 12
Table 3. Correlations between anthropometric z-scores and age at assessment, CARS, and IQ.
Cephalic Index Z-Score Facial Index Z-Score Intercanthal Index Z-Score Nasal Index Z-Score Mouth-Face Index Z-Score
r p-Value r p-Value r p-Value r p-Value r p-Value
Age 0.330 0.060 −0.061 0.732 0.143 0.426 −0.044 0.807 0.001 0.999
CARS 0.315 0.073 −0.505 0.002 0.384 0.027 −0.274 0.122 −0.029 0.870
Global IQ −0.231 0.194 0.348 0.046 −0.121 0.499 0.137 0.444 0.074 0.678
VQ −0.290 0.101 0.316 0.072 −0.253 0.154 0.119 0.506 0.058 0.747
nVQ −0.182 0.308 0.328 0.061 0.012 0.944 0.208 0.244 0.036 0.838
Posture and muscle tone 0.432 0.012 −0.293 0.097 0.278 0.116 −0.196 0.272 0.192 0.283
Reflex abnormalities 0.186 0.299 0.049 0.785 0.381 0.028 −0.259 0.145 0.174 0.332
Involuntary movements 0.042 0.812 −0.145 0.419 0.276 0.118 0.184 0.304 −0.205 0.252
Coordination and balance 0.203 0.255 −0.081 0.652 0.132 0.461 −0.233 0.191 −0.015 0.933
Fine motor dysfunction −0.094 0.609 0.011 0.948 0.296 0.096 −0.093 0.604 −0.322 0.067
Associated Movements 0.158 0.378 −0.298 0.091 0.154 0.391 −0.021 0.906 −0.048 0.788
Sensory deficits 0.547 <0.001 −0.532 0.001 0.064 0.720 −0.088 0.626 0.206 0.248
Cranial nerve
dysfunction 0.034 0.846 −0.015 0.931 0.175 0.329 0.278 0.116 −0.099 0.581
s-MND −0.448 0.008 0.271 0.126 −0.244 0.170 0.118 0.511 −0.083 0.644
c-MND 0.469 0.005 −0.468 0.005 0.245 0.168 −0.150 0.403 0.013 0.941
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Since CARS score has previously been linked to intellectual functioning (Militerni 2002 et al. [26]
in our study, r = 0.683, p < 0.001), standard multiple regression analyses were performed to
clarify the relationships between anthropometric z-scores, as dependent variables, and demographic
characteristics; global QI, CARS and MNDs (Table 4). For the sake of simplicity, only coefficients with
significant or borderline p-values were reported. The regressions’ results confirm that the cephalic
index was positively correlated with sensory deficits (coeff = 1.10, p-value = 0.013) (Table 4). Moreover,
facial index is negatively correlated with CARS score (p-value = 0.035), for every one-unit increase
in CARS score, the facial index z-score decreased by 0.118. The presence of sensory deficits is associated
with a decrease of 1.332 in the z-score of facial index (p-value = 0.005) (Table 4).
Table 4. Standard multiple regression analyses on anthropometric z-scores as dependent variables and
demographic characteristics, global QI, CARS and MND.
Coef 95%CI p-Value
Cephalic Index
Intercept −5.455 −10.786 −0.125 0.045
Fine motor dysfunction −0.899 −1.827 0.028 0.056
Sensory deficits 1.100 0.253 1.948 0.013
Facial Index
Intercept 4.017 −1.591 9.626 0.150
CARS −0.118 −0.227 −0.009 0.035
Reflex abnormalities 2.070 −0.355 4.497 0.090
Sensory deficits −1.332 −2.225 −0.441 0.005
Intercanthal Index
Intercept −4.229 −9.392 0.933 0.102
Global IQ 0.025 −0.001 0.051 0.063
Mouth-Face Index
Intercept 0.016 −5.156 5.188 0.995
Fine motor dysfunction −0.842 −1.742 0.059 0.065
Coef = Regression coefficients; 95%CI = 95% Confidence interval; The bold is for a better understanding of
anthopometrical variables.
The standard linear regression with CARS as dependent variable, showed that, an increase
in the intercanthal index was linked to an increase in CARS score (p-value < 0.001); for every one-unit
increase in the intercanthal index, the CARS score increased by 1.877. CARS score was negatively
associated with posture and muscle tone (coeff =−3.155, p-value = 0.027) and acial Index (p-value = 0.004),
for every one-unit increase in the facial index, the CARS score decreased by 1.410 (Table 5).
Figure 2 represents the results of the linear regression with CARS score as dependent variable.
In the 3D plot, the red points represent children with dysfunction in posture and muscle tone; black
points represent children without dysfunction in posture and muscle tone. The corresponding linear
planes were created with the linear regression coefficients computed fixing the level of global QI at
60—the mean value in our sample.
The results of the linear regression with global QI as response variable, revealed that it was
negatively correlated with MND (coeff = −11.646, p-value < 0.001) and positively correlated with
the intercanthal index (coeff = 8.805, p-value = 0.002), net of the CARS score. However, an increase
in the number of minor neurological dysfunction is associated with a lower global QI, while an increase
in the intercanthal index is associated with an increase in the global QI (Table 5).
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Table 5. Standard linear regression analyses on CARS and Global QI as dependent variables.
Coef 95%CI p-Value
CARS
Intercept 39.035 35.286 42.784 <0.001
Global QI −0.138 −0.191 −0.085 <0.001
Posture and muscle tone −3.155 −5.944 −0.367 0.027
Facial Index −1.410 −2.338 −0.482 0.004
Intercanthal Index 1.877 0.751 3.004 0.001
Global QI
Intercept 162.072 126.819 197.326 <0.001
CARS −2.674 −3.894 −1.455 <0.001
Total MND −11.646 −16.631 −6.663 <0.001
Coordination and balance 9.262 −3.752 22.278 0.155
Facial Index −4.016 −8.620 0.587 0.084
Intercanthal Index 8.805 3.281 14.331 0.002
Coef = Regression coefficients; 95%CI = 95% Confidence interval.
Figure 2. 3D plot representing the coefficients of linear regression analysis on CARS as dependent variable.
4. Discussion
Children with ASD diagnoses comprise a heterogeneous population with significant variation
in; type, number and severity of social deficits, behavior, communication, and cognitive difficulties;
undoubtedly reflecting multiple etiologic origins. An initial step towards identifying etiologically
discrete autism subgroups, is the discovery of discrete, quantifiable and patho-physiologically relevant
phenotypic features present in some, but not all, ASD subjects [8].
In the literature, MPAs and MNDs have been identified as putative biomarkers in providing insight
into early neurodevelopment [5,6,14,15]. The causes of autism may be (epi) genetically determined,
mildly associated with gene activity in early development, or result from prenatal environmental
risk factors [27]. This suggests that a putative biomarker may well have neurodevelopmental origins.
Furthermore, craniofacial anomalies and sensorimotor impairments are strongly associated with
structural abnormalities in the brain, which are correlated with clinical severity in ASD [14,15,28].
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Recent studies [9–11] showed that children diagnosed with ASD have a distinctive facial phenotype,
which correlates with symptom severity, suggesting a biological and anatomical subset of ASD.
Similarly, MNDs may indicate, disruption to fronto-striatal pathways and basal ganglia, as well
as alterations in the cerebellar region and brain stem. However, no particular sensorimotor
symptomatology is uniquely identified as ASD [29,30].
To our knowledge no previous study has examined the relationships between ASD facial phenotype
and MNDs.
Our recent research [11] identified a dolichocephalic head shape in ASD children, which did not
correlate with autism severity. This finding was compatible with previous research, showing that brain
and head size is a relatively non specific finding in autism [27] and suggesting an abnormal brain
growth trajectory during the in-utero period, after the 22nd week of amenorrhea, in children with ASD
who showed postnatal head overgrowth [31].
The current study found a direct correlation between dolichocephalic head shape and c-MND and
an inverse correlation with s-MND. Complex MND can be considered as a distinct form of perinatally
acquired brain dysfunction, which is likely to be associated with a structural deficit in the brain [14].
Moreover, with respect to specific MNDs, dolichocephaly head shape is associated with sensory
anomalies, but does not correlate with autism severity.
Frequently occurring types of neurological dysfunction, can been linked to specific parts of
the brain. They suggest dysfunction in cortical structures (dysfunction in fine manipulative abilities),
in cerebellar–brainstem circuitries (sensory deficits and dysfunctional regulation of posture and muscle
tone and coordination), and more global dysfunction (excess of associated movements, which may
point to immature or inadequate pathways and/or requiring more effort to perform movements) [32].
The link between dolichocephalic head shape and sensory deficits in our ASD group, could suggest
a strong contribution of dysfunction of subcortical structures in brain growth trajectory. However,
the finding that an increase in the number of MNDs is associated with lower global QI, represents
a limitation in the generalizability of our result, and adds to the evidence [33] for an independent
association between minor neurological impairment and cognitive performance.
On the other hand, our previous research [11] identified two craniofacial characteristics directly
associated with autism severity; increased inter-orbital distance and reduced height of the facial midline.
This ASD facial phenotype, supports the concept of a tight orchestration between atypical processes
governing the development of the “social brain” subcortical structures (such as the amygdala) during
gestation, and perturbations in the midline structures of the human embryonic face [7,9].
Our new data show a link between this ASD facial phenotype and anomalies in posture and
muscle tone, directly associated with autism severity.
In the literature the limbic structures represent key neural candidates, to orchestrate the rapid
integration of emotional inputs and motor output processes [34]. Recent findings suggest that,
in humans, the amygdala promotes protective motor reactions in emotionally-significant contexts,
and influences the execution of ongoing actions, by modulating functional interactions with
supplementary motor areas and interconnected motor pathways [35].
A recent study [36], has shown that the amygdala is altered in ASD, not only in terms of its
volume, but also in the microstructural properties of its connections to the cortex. These volumetric
and structural anomalies are associated with increased severity of the autistic phenotype, as measured
by impaired emotion recognition. Moreover, amygdala sub-regions may have specific associations
with ASD traits.
So, the link between this specific facial phenotype and anomalies in motor responses, could be
suggestive of early brain dysmaturation involving the amygdala, in cerebro-craniofacial development,
in ASD. This suggests a link to “social brain” functional (dys)morphology in ASD.
Intriguingly, our analysis also shows that the presences of sensory deficits, which are strongly
associated with ASD clinical criteria, are linked to a decrease in the height of the facial midline.
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This finding adds support to the pivotal role of subcortical structures in cerebro-craniofacial
development of autistic children.
Several limitations can be identified in the current study. The primary limitation was a lack of
genetic data. ASD is a heterogeneous disorder; it does not have a single physical phenotype which
would be suggestive of an underlying genetic syndrome. We excluded ASD children with comorbid
gross dysmorphic features, due to the direct association in literature [37] between the severity of
physical anomalies and increased likelihood of finding cytogenetic alterations.
Indeed, genetic testing methods, such as high-resolution karyotype and chromosomal microarray,
are now considered first-tier testing for individuals with ASD, developmental delay, and multiple
congenital anomalies. However, these are not universally obtained by medical providers in clinical
practice [37].
Similarly, we did not obtain neuroimaging data for our ASD subjects, but the results of our study
add to findings from existing neuroimaging data identifying abnormalities in; basal ganglia, thalamus,
supplementary motor areas and cerebellum; as a likely source of sensory-motor impairment in autism
spectrum disorder [24,37].
Our results could have clinical relevance for evaluation and treatment of children with ASD and
other Neurodevelopmental disorders. Children with a distinctive craniofacial phenotype (e.g., fetal
alcohol spectrum disorders), who lack the classic facial phenotype on external exam, but who have
significant differences in shapes and volumes, may be considered candidates for further neuroimaging
investigations of brain abnormalities and underlying genetic disorders [38].
The second limitation of this study was its relatively small sample size. Moreover, the study
population was limited to Caucasian patients, as ethnicity can influence the prevalence of morphological
abnormalities. Future studies are required to establish similar norms for other ethnic groups.
Thirdly, our methodology of 2D photogrammetry is limited to Euclidean measurement-although
it has the advantage of being a significantly less expensive approach than 3D measurement techniques.
In conclusion our work suggests a direct association between craniofacial development and
specific neurological anomalies in ASD; and supports preliminary the concept of a “social brain”
functional (dys)morphology in autism spectrum disorders.
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